Concepedia

Kumar G. Janoria

KG

11

Publications

854

Citations

10

H-Index

2005

Active since

Affiliations

University of Missouri–Kansas City(Current)

Center for Drug Evaluation and Research

United States Food and Drug Administration

Kumar G. Janoria is an author at University of Missouri–Kansas City specializing in pharmacology, biomedical engineering, and medicine.

Top concepts

Publications per year

2005–2020

11

Publications

11

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 315 citations · Full text

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Gwynn Ison, Lynn Howie, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2018 · 125 citations

Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA–PEG–PLGA gel for sustained delivery of ganciclovir

Sridhar Duvvuri, Kumar G. Janoria, Ashim K. Mitra · Journal of Controlled Release · 2005 · 110 citations

, , +8

Effect of Polymer Blending on the Release of Ganciclovir from PLGA Microspheres

Sridhar Duvvuri, Kumar G. Janoria, Ashim K. Mitra · Pharmaceutical Research · 2005 · 68 citations

, , +6

Controlled Delivery of Ganciclovir to the Retina with Drug-Loaded Poly(D,L-lactide-co-glycolide) (PLGA) Microspheres Dispersed in PLGA-PEG-PLGA Gel: A Novel Intravitreal Delivery System for the Treatment of Cytomegalovirus Retinitis

Sridhar Duvvuri, Kumar G. Janoria, Dhananjay Pal et al. · Journal of Ocular Pharmacology and Therapeutics · 2007 · 63 citations

Rows per page

1–5 of 11